To fight current and future pandemics more effectively, Mirte Pascha closely studies the influenza virus. The corona pandemic underlines the importance of her work.

PhD student Patrick Dekker is working on a drug to kill pathogenic microorganisms. The key? Clocking the trash cans of the pathogenic cells.

Pathogens in the lungs can adapt to their environment in order to survive antibiotic treatment. Maik Kok is studying the role of metabolism in this process and the resulting effects on antibiotic resistance.

Goat farms may specifically host pneumonia-causing micro-organisms. Wouter Lokhorst identifies microbes on these farms to obtain a better insight into causative agents of pneumonia.

By developing models that behave a lot like a human liver, Linda van den Berk will be able to study the interaction between liver inflammation and side effects in the liver caused by medicines.

In the last decade, bacteria-killing viruses have gained popularity as alternatives for antibiotics. Michèle Molendijk investigates the safety and efficiency of these bacteria killers as drugs.

Scientists study viruses and ways to combat them in petri dishes containing a flat layer of cells. Danny Noack builds ‘tiny human tissues’ to study viruses in a more natural environment.

In the battle against antibiotic resistance, Alexander Bakker is testing existing chemical compounds to see whether they can be used as antibiotics. These compounds were originally created to treat cancer and other diseases.